Navigation Links
BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations

INDIANAPOLIS, Feb. 26 /PRNewswire/ -- BioStorage Technologies, Inc. (BST), announces the appointment of Dr. Wolfgang Hoffer as Managing Director of the company's European operations in Griesheim, Germany. Hoffer joins BST with nearly 20 years of management experience in the fields of clinical pharmacology and toxicology. In his new role, Hoffer will report directly to James M. Saponaro, Chief Operating Officer for BST, and will manage all aspects of BST's Europe Division, including sales and marketing, operations and finance.

Dr. Hoffer has previously held positions with MOMENTUM Pharma Services, MDS Pharma Services, PAREXEL(R) International, The Boston Consulting Group and Solvay Pharma. Most recently, he was site director of MOMENTUM Pharma Services' Hamburg, Germany, location, following its spinout from MDS Pharma Services.

"Hoffer will focus on offering worldwide service to our global pharmaceutical clients while maintaining our standards of operational excellence," said F. John Mills, M.D., Ph.D., Chief Executive Officer and Chairman of the Board.

"We were looking for someone with broad, credible experience in the pharmaceutical and contract research industry. Not only does Wolfgang have the right level of industry experience and credentials, but he also has a first- rate, entrepreneurial spirit. We wanted someone who is willing to roll up his sleeves and get things done, and he is definitely that kind of individual," said Mills.

Dr. Hoffer holds a doctorate in physiological chemistry from the University of Veterinary Medicine Hannover (Germany), and is a certified veterinarian in the German state of Bavaria. Dr. Hoffer began his educational career studying chemistry and biology at the University of Kaiserslautern (Germany).

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is a worldwide leader in sample storage, inventory management and cold-chain logistics for the biotechnology and pharmaceutical industries throughout the research, clinical trial and commercialization phases of drug development. The company offers secure, temperature-controlled storage; real-time tracking of stored biological samples; and next-day return of biomaterials. BioStorage Technologies is privately-held and headquartered in Indianapolis with an additional full- service site near Frankfurt, Germany. For more information about the company, please visit or call +1 (866) 697-2675 or +49 615 582 4490.

SOURCE BioStorage Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Appoints Lori Ball as Vice President
2. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
3. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
4. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
5. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
6. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
7. NASA MidSTAR-1 successful technologies may be revolutionary
8. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
9. Neurobiological Technologies Sets Date for Research and Development Day
10. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.
11. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... on behalf of the Toronto Stock Exchange, confirms that ... are no corporate developments that would cause the recent ... --> --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical ...
(Date:11/24/2015)... ... ... This fall, global software solutions leader SAP and AdVenture Capital brought together dozens ... BIG ideas to improve health and wellness in their schools. , Now, the top ... of SAP's Teen Innovator, an all-expenses paid trip to Super Bowl 50, and an ...
(Date:11/24/2015)... New York , November 24, 2015 ... to a recent market research report released by Transparency ... projected to expand at a CAGR of 17.5% during ... "Non-invasive Prenatal Testing Market - Global Industry Analysis, Size, ... estimates the global non-invasive prenatal testing market to reach ...
Breaking Biology Technology:
(Date:11/19/2015)... , Nov. 19, 2015  Based on its ... & Sullivan recognizes BIO-key with the 2015 Global Frost ... year, Frost & Sullivan presents this award to the ... catering to the needs of the market it serves. ... line meets and expands on customer base demands, the ...
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
Breaking Biology News(10 mins):